top of page

Erlotinib Tablet is indicated for:

  • The first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor(EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
  • The maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer, whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
  • The treatment of patients with locally advanced or metastatic non- small cell lung cancer after failure of at least one prior chemotherapy regimen.

Siddha Global is Supplier,Exporter ,Wholesaler  for Erlotinib Tablet 100mg & 150 mg in India.

We even  offer contract manufacturing services from WHO GMP approved factories.

ERLOTINIB TABLET 100MG & 150 MG

0,00₹Prix
  •  

bottom of page